PharmaCielo announced that it has made an initial shipment of CBD full spectrum oil containing THC to Extractions Solutions SL. This Spanish natural pharmaceutical company specializes in the post-processing and refinement of cannabis derivatives. Extractions Solutions intends to use PharmaCielo's product to develop CBD derivatives to be produced in Spain and distributed across Europe.
Management commentary
Bill Petron, CEO of PharmaCielo, commented, "We are pleased to announce our entrance into a new market, with the initial shipment of PharmaCielo API1 to Extractions Solutions, in support of their product development efforts. This serves to further expand our distribution network throughout Europe, building on our recent announcements that we will be bringing PharmaCielo products to the German and Polish medical cannabis markets. Our sales team has already made substantial progress in the first five months of 2022, and we expect to continue this trend through the rest of the year as we drive toward increased revenues and sustained profitability."
Dirk Eduard M. de Maeyer, Executive Director of Extractions Solutions, added, "Extractions Solutions is an innovative, rapidly growing cannabinoid post-processor, refiner, and manufacturer, with an established customer base across the European market. With a commitment to providing high-quality products and custom solutions, as well as seed-to-solution traceability, PharmaCielo was a logical choice as we continue to build out our product portfolio. PharmaCielo has the quality, consistency, sophistication, and scale that we require of our API partners, and we look forward to continuing to advance the relationship as we seek to serve our customers across the EU and globally."
For more information:
PharmaCielo
investors@pharmacielo.com
www.pharmacielo.com